Trial
NCT01394211
Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Arizona
Collaborators
National Cancer Institute (NCI); GlaxoSmithKline
Condition
Estrogen Receptor-positive Breast Cancer
Intervention
anastrozole
Why stopped
Slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-07-26